Application 062638
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ERYTHROCIN | ERYTHROMYCIN LACTOBIONATE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | ERYTHROCIN | ERYTHROMYCIN LACTOBIONATE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-6476 | Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | ANDA | Current |
| 0409-6476 | Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | ANDA | Current |
| 0409-6476 | Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | ANDA | Current |
| 0409-6476 | Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 18309 | SUPPL | 2014-01-31 |